What we're reading, February 2, 2016: Aetna joins other major insurers raising concerns over the Affordable Care Act's insurance exchanges; Sanofi announces plans to develop a Zika vaccine; and Martin Shkreli expected to testify despite dismissing the subpoena.
Aetna has now joined other major insurers who have raised concerns over the sustainability of the Affordable Care Act’s insurance exchanges. The New York Times reported that Aetna has struggled with consumers signing up outside of the open enrollment period. However, CMS recently dropped several special enrollment periods. Aetna is operating in 15 state-based exchanges and has enrolled 750,000 people, but lost more than $100 million on its exchange business in 2015.
As the World Health Organization declared the Zika virus a public health emergency on an international scale, Sanofi announced that it has launched a project to develop a vaccine for the virus, which has been linked to multiple birth defects in Brazil, according to Reuters. Small biotech companies and academic institutions also have plans to develop a vaccine, and GlaxoSmithKline is concluding feasibility studies on its vaccine technology.
Although he dismissed the subpoena, ex-Turing Pharmaceutical CEO Martin Shkreli is expected to appear on Thursday to testify before the House Oversight and Government Committee for the hearing “Developments in the Prescription Drug Market,” reported Roll Call. Other pharmaceutical representatives from Valeant Pharmaceuticals International, Inc, and the Pharmaceutical Care Management Association are expected to testify as well on Thursday.
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for Health and Human Services (HHS) leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More
Amid Search for Biomarkers in oGVHD, Research Focuses on Cytokine Profile of Tears
March 25th 2024A better understanding of biomarkers in ocular graft-vs-host disease (oGVHD) can help drive a more comprehensive understanding of the disease and improve patient outcomes, say researchers.
Read More